ALPHA3

NOW ENROLLING

The industry's first pivotal Phase 2 first‑line (1L) consolidation trial of an investigational allogeneic CAR T in large-B cell lymphoma (LBCL)

ALPHA3

PIVOTAL PHASE 2 ALPHA3 TRIAL INITIATED

Allogene initiates the industry's first pivotal first line (1L) consolidation trial of an investigational allogeneic CAR T in LBCL